ImmunoIVD focuses on neonatal screening for primary immunodeficiency diseases. The SPOT-it™ kit is CE marked and has been developed to facilitate population-scale screening to detect newborns with the most severe forms of T- and B-cell lymphopenic PID.
The company is built on a strong foundation with more than 30 years experience of successfully running a biotech company, and world renowned researchers within the field of clinical immunology and immunogenetics.
Early detection increases the chances for children born with SCID or other forms of PID to live life to its fullest. We believe all children should be given that chance.
Company’s Keywords:
primary immunodeficiency diseases, scid, newborn screening, immunology
<21
<
<2015
Your request has been submitted successfully.
Own or work here?